National Institutes of Health
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing November 5, 2027.
Nov 5, 2027
(462d left)